LAS VEGAS, Oct. 03, 2017 -- CV Sciences, Inc. (OTCBB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil, announces that its industry dominating brand of finished products, PlusCBD Oil™ will be exhibiting at Natural Products Association Expo Northwest as a Platinum Sponsor on October 13-14, 2017 in Portland, Oregon at the Portland Marriott Downtown Waterfront.
Produced by Natural Products Association Northwest (NPA NW), Expo Northwest is one of the leading regional trade shows in the natural, organic and healthy products industry and continues to grow year after year. NPA NW offers education and networking opportunities to natural foods retailers and suppliers representing Alaska, Colorado, Idaho, Montana, Nevada, Oregon, Utah, Washington and Wyoming.
Due to the unwavering support from retailers across the United States since the launch of its brand of dietary supplements in 2014, PlusCBD Oil™, #1 brand of hemp-derived CBD products in the natural channel according to SPINS data, has achieved immense success.
“CV Sciences is a Platinum Sponsor this year because sales are booming,” stated Stuart Tomc, VP of Human Nutrition and spokesperson at CV Sciences. “Our third year exhibiting at this trade show, we are proud to be a pioneer of hemp-derived CBD awareness in this region - a region filled with natural health retailers who understand the true promise of botanical nutrition and who have taken a chance on hemp. Because of these trailblazers, the hemp CBD category has grown and continues to thrive.”
KEYNOTE ADDRESS: Join the CV Sciences team for the Keynote Address, “The Cannabis Disruption: Bringing Hemp Back,” on Friday, October 13th from 11am to 12:30pm in the Salon A-B, Lower Level 1. Presenters Stuart Tomc and Josh Hendrix will cover the state of hemp-derived CBD in the United States marketplace, the importance of proper research steps in order to impact the future of hemp agriculture, and how CV Sciences demonstrates Full Traceability - From Seed to Shelf™.
VISIT BOOTH 19: Attendees of Expo Northwest are invited to visit Booth #19 to learn more about the company, its brand, and products from any of the CV Sciences' highly educated staff, who will be providing one-on-one education to retailers interested in carrying PlusCBD Oil™ products.
SHOW SPECIALS: CV Sciences offers exclusive trade show discounts and show specials to retailers placing orders at the show. Discounts will be honored through the week following Expo Northwest. Please see a CV Sciences associate for more information.
ABOUT CV SCIENCES: CV Sciences, Inc (OTCBB:CVSI), located in Las Vegas, Nevada, focuses on drug development activities on products containing cannabidiol (CBD) as the active pharmaceutical ingredient, and also is engaged in the sale of CBD, and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. Additional information is available from OTCMarkets.com or by visiting PlusCBDoil.com.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
CONTACT:
Robert Haag, Managing Director
IRTH Communications
[email protected]
866-976-4784


China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Pilots Fear Retaliation for Refusing Middle East Flights Amid Ongoing Conflict
OpenAI Addresses Security Vulnerability in macOS App Certification Process
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 



